a16z Capital Management, L.L.C.: DAMORA THERAPEUTICS INC (DMRA): Quarterly 13F Position History
As of Q2 2026, a16z Capital Management, L.L.C. reported 1,236,157 shares of DAMORA THERAPEUTICS INC (DMRA), worth $32.2M and representing 0.2% of its 13F equity book. The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 1,236,157Shares Held (Latest Filing)
- $32.2MReported Market Value (Latest Filing)
- 0.2%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- +$136.0KQuarter-over-Quarter Value Change
- 1,236,157Peak Reported Shares (Historical)
Recent initiation: a16z Capital Management, L.L.C. first reported DMRA on the Q1 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,236,157 | 0 | – | $32.2M | 0.2% | $26.0 |
| Q1 2026 | 1,236,157 | – | – | $32.0M | 2.5% | $25.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did a16z Capital Management, L.L.C. first disclose a DMRA position in 13F-HR filings?
a16z Capital Management, L.L.C. first reported DAMORA THERAPEUTICS INC (DMRA) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was a16z Capital Management, L.L.C.'s most recent quarter-over-quarter share-count change in DMRA?
a16z Capital Management, L.L.C. held the same 1,236,157 shares of DMRA between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent a16z Capital Management, L.L.C.'s cost basis in DMRA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.